HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Neutrogena: Advanced Solutions skin care range, rolling out this month, offers professional quality efficacy at home, Johnson & Johnson division says. Skin Transforming Complex comprises Nightly Renewal Cream ($23.99) and Daily SPF 15 Moisturizer ($23.99), which combat sings of aging with Retinol and AHAs, firm claims. Advanced Solutions Facial Peel ($24.99) is formulated with a CelluZyme technology, which delivers the results of a 20% glycolic acid peel with less irritation, according to the company. Complete Acne Therapy System ($29.99) rounds out the collection with three products designed to combat breakouts with salicylic acid and benzoyl peroxide - Skin Polishing Acne Cleanser, Sun-Shield Day Lotion and Overnight Acne Control Lotion...

You may also be interested in...



Neutrogena Introduces Helioplex Sun Care, Cleansing Pads

Neutrogena Helioplex sun care, formulated with stabilized avobenzone, "blocks more UVA rays than the leading sunscreens available in the U.S.," Johnson & Johnson claims

Neutrogena Introduces Helioplex Sun Care, Cleansing Pads

Neutrogena Helioplex sun care, formulated with stabilized avobenzone, "blocks more UVA rays than the leading sunscreens available in the U.S.," Johnson & Johnson claims

J&J Study Shows Home Microderm Efficacy On Par With Professional

Subjects who used a home microdermabrasion system experienced a "similar improvement for virtually all clinically assessed skin parameters" compared to those who received a dermatologist-administered microderm treatment after one and four weeks, according to a study conducted by James Leyden, MD, University of Pennsylvania, et al. in collaboration with Johnson & Johnson researchers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel